The RG motif in p110α is asymmetrically dimethylated by PRMT1, and the increase of arginine methylation in p110α inhibits SGs assembly, thereby inhibiting HCC resistance to sorafenib and HCC progression. This evidence concerns the gene PRMT1 and hepatocellular carcinoma.